E. Karavia

发表

High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?

Kyriakos E Kypreos, E. Zvintzou, Dimitra Sotiria Karampela, 2021, Vascular pharmacology.

Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.

G. Maulucci, C. Constantinou, S. Sasson, 2019, Biochimica et biophysica acta. Molecular basis of disease.

Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function.

C. Kalogeropoulou, G. Sakellaropoulos, C. Constantinou, 2016, Biochemistry.

Scavenger Receptor Class B Type I Regulates Plasma Apolipoprotein E Levels and Dietary Lipid Deposition to the Liver.

G. Sakellaropoulos, C. Constantinou, D. Papachristou, 2015, Biochemistry.

Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice.

J. Berbée, A. Spyridonidis, Kyriakos E Kypreos, 2015, Biochimica et biophysica acta.

Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet.

I. Lilis, I. Triantaphyllidou, D. Papachristou, 2013, Osteoarthritis and cartilage.

Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice

D. Deligianni, C. Kontoyannis, H. Blair, 2016, Laboratory Investigation.

Deficiency in apolipoprotein E has a protective effect on diet‐induced nonalcoholic fatty liver disease in mice

I. Giopanou, D. Papachristou, Kyriakos E Kypreos, 2011, The FEBS journal.

Strain-specific Differences in the Effects of Lymphocytes on the Development of Insulin Resistance and Obesity in Mice.

P. Tsakanikas, N. Kostomitsopoulos, K. Karalis, 2018, Comparative medicine.

Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review

P. Gourzis, M. Skokou, Kyriakos E Kypreos, 2022, Pharmaceuticals.

Apolipoprotein A-I Modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

I. Triantaphyllidou, D. Papachristou, Kassiani Liopeta, 2012, Molecular medicine.

Benefits of a fixed-dose combination of standardized P. mume extract with choline on adipose tissue mitochondrial metabolic activity and pancreatic β-islet secretory capacity in mice

G. Panayiotakopoulos, D. Papachristou, Kyriakos E Kypreos, 2022, Phytomedicine Plus.

Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.

D. Papachristou, Kyriakos E Kypreos, E. Karavia, 2013, The Journal of nutritional biochemistry.

Isoform and tissue dependent impact of apolipoprotein E on adipose tissue metabolic activation: The role of apolipoprotein A1.

C. Kalogeropoulou, C. Constantinou, Kyriakos E Kypreos, 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Western-type diet differentially modulates osteoblast, osteoclast, and lipoblast differentiation and activation in a background of APOE deficiency

H. Blair, G. Tzanakakis, D. Papachristou, 2018, Laboratory Investigation.

Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation.

C. Kalogeropoulou, C. Constantinou, Kyriakos E Kypreos, 2018, Biochimica et biophysica acta. Molecular basis of disease.

Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities

C. Constantinou, G. Panayiotakopoulos, R. Bitzur, 2018, Angiology.

Tissue-specific Functional Interaction Between Apolipoproteins A1 and E in Cold-Induced Adipose Organ Mitochondrial Energy Metabolism.

Kyriakos E Kypreos, E. Zvintzou, E. Xepapadaki, 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

HDL quality and functionality: what can proteins and genes predict?

C. Constantinou, Kyriakos E Kypreos, E. Zvintzou, 2014, Expert review of cardiovascular therapy.

Mechanisms of obesity and related pathologies: Role of apolipoprotein E in the development of obesity

Elisavet H. Fotiadou, Smaragda M. Giakoumi, E. Tsompanidi, 2009, The FEBS journal.

Advances in high-density lipoprotein physiology: surprises, overturns, and promises.

C. Kalogeropoulou, C. Constantinou, G. Panayiotakopoulos, 2016, American journal of physiology. Endocrinology and metabolism.

Medicines for Obesity: Appraisal of Clinical Studies with Grading of Recommendations, Assessment, Development, and Evaluation Tool

T. Filippatos, Demosthenes Panagiotakos, Kyriakos E Kypreos, 2023, Nutrients.

Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition.

C. Kalogeropoulou, C. Constantinou, D. Papachristou, 2015, European journal of pharmacology.

Deficiency in apolipoprotein E has a protective effect on diet‐induced nonalcoholic fatty liver disease in mice

I. Giopanou, D. Papachristou, Kyriakos E Kypreos, 2011, The FEBS journal.

Apolipoprotein A-I Modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

I. Triantaphyllidou, D. Papachristou, Kassiani Liopeta, 2012, Molecular medicine.